Status:
COMPLETED
Epidemiology of Thrombotic Thrombocytopenia Syndrome in Integrated Health-care Database in England
Lead Sponsor:
AstraZeneca
Conditions:
COVID-19
Eligibility:
All Genders
Brief Summary
Background/Rationale: A rare syndrome of thrombosis associated with low platelets has been reported in a few cases of recent exposure to COVID-19 vaccine. Medicines \& Healthcare products Regulatory A...
Eligibility Criteria
Inclusion
- All patients, with a primary focus from age 16 years old and older, in England who are present in the integrated database at the start of each study period.
Exclusion
- Less than 12 months of prior history at start of each respective study period.
Key Trial Info
Start Date :
March 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 25 2023
Estimated Enrollment :
41200246 Patients enrolled
Trial Details
Trial ID
NCT05222750
Start Date
March 1 2022
End Date
May 25 2023
Last Update
December 11 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Oxford, United Kingdom, OX12JD